IVIG has proven to be highly effective in many pediatric conditions:
1. Kawasaki Disease: Studies show that IVIG, when administered early, significantly reduces the risk of coronary artery aneurysms. 2. ITP: IVIG can rapidly increase platelet counts in children, reducing bleeding risks. 3. GBS and CIDP: IVIG has shown significant improvement in muscle strength and function, often reducing the need for prolonged hospitalization.
